Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ChemBioEng Reviews is Scopus-indexed (Q1, CiteScore 13.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 2196-9744Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: About US$4,030 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Industrial and Manufacturing Engineering | 31 / 425 | 92nd | Q1 |
| Biochemistry | 34 / 448 | 92nd | Q1 |
| Bioengineering | 19 / 168 | 88th | Q1 |
| Process Chemistry and Technology | 10 / 84 | 88th | Q1 |
| Chemical Engineering (miscellaneous) | 15 / 106 | 86th | Q1 |
| Filtration and Separation | 6 / 21 | 73rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 13.8.
ChemBioEng Reviews is Q1 in Industrial and Manufacturing Engineering (rank 31 of 425), Q1 in Biochemistry (rank 34 of 448) and Q1 in Bioengineering (rank 19 of 168), by CiteScore 2025. It is ranked in 6 subject areas in all.
ChemBioEng Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.8, which places it in quartile Q1 at the 92nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.285, quartile Q1, with an H-index of 54.
The publisher lists an article processing charge of about US$4,030 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ChemBioEng Reviews is published by Wiley-Blackwell Publishing Ltd. Its ISSN is 2196-9744.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
ChemBioEng Reviews has an h-index of 59 and a 2-year mean of 7.01 citations per paper (OpenAlex). Its Scopus CiteScore is 13.8, quartile Q1. On 2-year citations it ranks #35 of 359 Scopus journals in Industrial and Manufacturing Engineering.
ChemBioEng Reviews published 57 papers in 2025; its busiest recent year was 2023 with 87. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2024–2026), authors are most often from India (17.4%), China (15.4%) and Malaysia (8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.